TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
1-Year Return
35.44%
This Quarter Return
+25.92%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$269M
AUM Growth
-$59.6M
(-18%)
Cap. Flow
-$73.8M
Cap. Flow
% of AUM
-27.47%
Top 10 Holdings %
Top 10 Hldgs %
55.73%
Holding
84
New
36
Increased
10
Reduced
12
Closed
25
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$21.1M |
| 2 |
Medtronic
MDT
|
$14.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$8.66M |
| 4 |
Legend Biotech
LEGN
|
$8.06M |
| 5 |
DexCom
DXCM
|
$6.66M |
Top Sells
| 1 |
Abbott
ABT
|
$17.7M |
| 2 |
Tandem Diabetes Care
TNDM
|
$17M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$16.3M |
| 4 |
ARK Innovation ETF
ARKK
|
$14.1M |
| 5 |
Sarepta Therapeutics
SRPT
|
$12.3M |
Sector Composition
| 1 | Healthcare | 99.2% |
| 2 | Financials | 0.24% |
| 3 | Industrials | 0.21% |
| 4 | Energy | 0.12% |
| 5 | Technology | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETRN
76
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| – | – |
-10,131
| Closed | -$58.6K |
|
|
ISEE
77
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-106,711
| Closed | -$2.6M |
|
|
RXDX
78
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-28,470
| Closed | -$3.06M |
|
79
Inspire Medical Systems
INSP
$2.55B
| – | – |
-17,523
| Closed | -$4.1M |
|
80
Merck
MRK
$210B
| – | – |
-114,242
| Closed | -$12.2M |
|
|
PGRE
81
Paramount Group
PGRE
$1.63B
| – | – |
-15,008
| Closed | -$68.4K |
|
|
UNIT
82
Uniti Group
UNIT
$1.54B
| – | – |
-11,370
| Closed | -$40.4K |
|
83
Viking Therapeutics
VKTX
$2.98B
| – | – |
-200,000
| Closed | -$3.33M |
|
|
SWN
84
DELISTED
Southwestern Energy Company
SWN
| – | – |
-10,357
| Closed | -$51.8K |
|